Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Judson

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Gynecologic Oncology|May 22, 2016
Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapyI Ray-Coquard, E Rizzo, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2014
Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I databaseP A Cassier, V Polivka, I Judson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2012
Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapyN Penel, G D Demetri, J Y Blay, et al.
Pediatric Blood & Cancer|January 24, 2017
Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study)Brice Fresneau, A Hackshaw, D S Hawkins, et al.
European Radiology|May 8, 2012
Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imagingM O Leach, B Morgan, P S Tofts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2020
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma NetworkG D Demetri, C R Antonescu, B Bjerkehagen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2018
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2018
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2018
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Gynecologic Oncology|May 22, 2016
Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapyI Ray-Coquard, E Rizzo, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2014
Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I databaseP A Cassier, V Polivka, I Judson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2012
Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapyN Penel, G D Demetri, J Y Blay, et al.
Pediatric Blood & Cancer|January 24, 2017
Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study)Brice Fresneau, A Hackshaw, D S Hawkins, et al.
European Radiology|May 8, 2012
Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imagingM O Leach, B Morgan, P S Tofts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2020
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma NetworkG D Demetri, C R Antonescu, B Bjerkehagen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2018
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2018
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2018
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upP G Casali, N Abecassis, H T Aro, et al.
Pageof 12